BSTG - Biostage Inc Announces the Publication of Mechanical Strength Data for Regenerated Esophageal Tissue in Biomechanical Journal (BSTG)

A cell-therapy biotechnology company, Biostage Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), has announced today the publication of a paper in the peer-reviewed Journal of Biomechanics. This published paper describes a study investigating the mechanical strength of regenerated esophageal tissues. Biostage is a biotechnology company with a successful first-in-human experience repairing the esophagus after cancer surgery. The company has FDA approval to commence a clinical trial for Biostage Esophageal Implant for acute esophageal diseases such as cancer.

The Biostage Esophageal Implant, formerly called Cellspan Esophageal Implant, stimulates the regeneration of new tissue after segmental resection of ...